3125-73-3 Usage
Description
3-IODOPHENYL ISOTHIOCYANATE, also known as m-iodophenyl isothiocyanate, is an isothiocyanate derivative characterized by its density of 1.8000g/cm3 at 25°C. It is a chemical compound with potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
3-IODOPHENYL ISOTHIOCYANATE is used as a synthetic intermediate for the development of radiopharmaceutical compounds. Its unique chemical properties allow it to be incorporated into the synthesis process, enabling the creation of diagnostic and therapeutic agents for various medical applications.
Used in Radiochemistry:
3-IODOPHENYL ISOTHIOCYANATE is used as a precursor in the synthesis of radiolabeled compounds for research and clinical purposes. Its reactivity and compatibility with radionuclides make it a valuable component in the development of novel imaging agents and targeted therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 3125-73-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,2 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3125-73:
(6*3)+(5*1)+(4*2)+(3*5)+(2*7)+(1*3)=63
63 % 10 = 3
So 3125-73-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H4INS/c8-6-2-1-3-7(4-6)9-5-10/h1-4H
3125-73-3Relevant articles and documents
Design, synthesis, biological activities, and dynamic simulation study of novel thiourea derivatives with gibberellin activity towards Arabidopsis thaliana
Yang, Zhikun,Wang, Jine,Tian, Hao,He, Yan,Duan, Hongxia,Duan, Liusheng,Tan, Weiming
, (2019/07/03)
Computer-aided drug design has advanced by leaps and bounds, and has been widely used in various fields, and especially in the field of drug discovery. Although the crystal structure of the gibberellin (GA) receptor GID1A had been reported in previous studies, there is still a lack of designs of gibberellin functional analogue based GID1A. In the present study, a series of 30 thiourea derivatives were designed, synthesized and biologically assayed. The results suggested that the synthetic compounds had good GA-like activities. Furthermore, the structure-activity relationship of the synthetic compounds was discussed, and the dynamic simulation and docking study revealed the binding properties of the GID1A receptor and compounds Y1, Y11, and Y21.
